Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Dr Ed Clarke

Professor - Theme Leader

United Kingdom

Jump to: Affiliations Publications

Affiliations
MRC Unit The Gambia at LSHTM

Selected Publications
Immune responses to human papillomavirus infection and vaccination.
Kiamba, EW; GOODIER, MR; CLARKE, E;
2025
Frontiers in immunology
The waning of maternal measles antibodies: A multi-country maternal-infant seroprevalence study
Tiley, KS; Ten Hulscher-van Overbeek, H; Basnet, S; Van Binnendijk, R; CLARKE, E; COSE, S; Dang, DA; Hoang, HT T; Holder, B; Idoko, OT; KAMPMANN, B; Kibengo, F; Van der Klis, F; Kazi, AM; Leuridan, E; Maertens, K; Maldonado, H; Nyantaro, M; Omer, S; Pasetti, MF; Pollard, AJ; Rots, N; Sharma, AK; Shrestha, S; Tapia, M; ... Voysey, M.
2025
Journal of Infection
Interactions between live attenuated influenza vaccine and nasopharyngeal microbiota among children aged 24-59 months in The Gambia: a phase 4, open-label, randomised controlled trial.
Peno, C; Jagne, YJ; Clerc, M; Balcazar Lopez, C; ARMITAGE, EP; Sallah, H; Drammeh, S; Senghore, E; Goderski, G; Van Tol, S; Meijer, A; Ruiz-Rodriguez, A; De Steenhuijsen Piters, WA A; De Koff, E; JARJU, S; Lindsey, BB; Camara, J; Bah, S; MOHAMMED, NI; KAMPMANN, B; CLARKE, E; Dockrell, DH; DE SILVA, TI; Bogaert, D;
2025
The Lancet. Microbe
Immunogenicity of yellow fever vaccine co-administered with 13-valent pneumococcal conjugate vaccine in rural Gambia: A cluster-randomised trial.
OSEI, I; Schmidt-Chanasit, J; Licciardi, PV; Secka, O; D'ALESSANDRO, U; Salaudeen, R; Sarwar, G; CLARKE, E; MOHAMMED, NI; Nguyen, C; GREENWOOD, B; Jansen, S; MACKENZIE, GA;
2025
Vaccine
Booster Vaccination against Yellow Fever in Gambian children-(BoVY) -a Phase 3 clinical trial to establish safety and immunogenicity of repeated YF vaccination in healthy Gambian children of different ages.
KAMPMANN, B; Pley, C; STRANDMARK, J; Leigh, MN; Ndow, P; CLARKE, E; Roberts, E; FAAL, A; JEFFRIES, D; Kanteh, E;
2024
Wellcome open research
Measles-Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and Considerations.
Zehrung, D; Innis, BL; Suwantika, AA; Ameri, M; Biellik, R; Birchall, JC; Cravioto, A; Jarrahian, C; Fairlie, L; Goodson, JL; Kochhar, S; Kretsinger, K; Morgan, C; Mvundura, M; Rathi, N; CLARKE, E; Mistilis, JJ; Uwamwezi, M-C; Giersing, B; Hasso-Agopsowicz, M;
2024
Vaccines
Collecting and reporting adverse events in low-income settings-perspectives from vaccine trials in the Gambia.
BRUCE, AA-A; Umesi, A-O; Bashorun, A; Ochoge, M; Yisa, M; Obayemi-Ajiboye, D; Futa, A; Njie, A; Asase, S; Jallow, MB; Kotei, L; Affleck, L; Olubiyi, OA; Jarju, LB; Kanyi, M; Danso, B; Zemsi, A; CLARKE, E;
2024
Trials
A measles and rubella vaccine microneedle patch in The Gambia: a phase 1/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trial.
Adigweme, I; Yisa, M; OOKO, M; Akpalu, E; Bruce, A; Donkor, S; Jarju, LB; Danso, B; Mendy, A; JEFFRIES, D; Segonds-Pichon, A; Njie, A; Crooke, S; El-Badry, E; Johnstone, H; Royals, M; Goodson, JL; Prausnitz, MR; McAllister, DV; Rota, PA; Henry, S; CLARKE, E;
2024
Lancet (London, England)
Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial.
Ochoge, M; Futa, AC; Umesi, A; Affleck, L; Kotei, L; Daffeh, B; Saidy-Jah, E; Njie, A; Oyadiran, O; Edem, B; Jallow, M; Jallow, E; Donkor, SA; Tritama, E; Abid, T; Jones, KA V; Mainou, BA; Konz, JO; Fix, A; Gast, C; CLARKE, E;
2024
Lancet (London, England)
Practical Guidelines for Standardised Resolution of Important Protocol Deviations in Clinical Trials Conducted in Sub-Saharan Africa.
Zemsi, A; Nekame, LJ G; MOHAMMED, N; Batchilly, ES; Dabira, E; Sillah, SO; Sey, G; Williams, DH; Dondeh, B-L; CERAMI, C; CLARKE, E; D'ALESSANDRO, U;
2024
Therapeutic innovation & regulatory science
See more information
Ed Clarke

Contact

United Kingdom